NovaBay Pharmaceuticals, Inc. (B9P0.F)

0.0000 -2.8000 (-100.00%) 收市：08:23AM CEST

NovaBay Pharmaceuticals, Inc.

2000 Powell Street
Suite 1150, eleventh floor
Emeryville, CA 94608
United States
510 899 8800
https://novabay.com

版塊: Healthcare
行業: Biotechnology
全職員工: 24

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Justin M. Hall Esq.	President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director	340.07k	無	1978
Mr. Tommy Law	Controller, Interim CFO & Treasurer	165.94k	無	1985

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 。

描述

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

公司管治

截至 無 止，NovaBay Pharmaceuticals, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。